Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Roche Holding AG
Breaking News: Markets
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Health & Science
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Health & Science
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Business News
Health & Science
Breaking News: Business
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Stock Picks
Investment strategy
Markets
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
CVS Health Corp
Health care industry
Eli Lilly and Co
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Market Outlook
Artificial intelligence
Laws
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
Goldman Sachs Group Inc
Breaking News: Technology
Government and politics
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Weight management
Science
Mondelez International Inc
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Deutsche Bank AG
Science
Health care industry
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Health & Science
Healthy Returns
Gilead Sciences Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Health & Science
Science
Healthy Returns
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Technology
Markets
NVIDIA Corp
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Biotech and Pharmaceuticals
Europe News
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Europe News
Novo Nordisk A/S
Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Health care industry
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Business
Pharmaceuticals
Biotechnology
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
Voting
World Markets
Ibex Ltd
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Small Business
Small business
Small Business: Management
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
Investing
Business News
U/S/ Markets
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Exchange/traded funds
Zealand Pharma A/S
Eli Lilly and Co
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
WW International Inc
Novo Nordisk A/S
Internet
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Healthy Returns
Eli Lilly and Co
Science
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
AstraZeneca PLC
Business News
Medicine
From
CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
May 20, 2024
Tags
Technology
Enterprise
Internet
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Carmot Therapeutics Inc
Breaking news
Business
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Alphabet Inc
Science
Health care industry
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.